Anti-Infective Agents Market Growth, Future Prospects And Competitive Analysis (2022--2028)

The Anti-Infective Agents Market is expected to grow from US$ 1,35,961.03 million in 2022 to US$ 1,64,196.61 million by 2028; it is estimated to grow at a CAGR of 3.19% from 2022 to 2028.

Anti-Infectives are medications that help in preventing and treating infections, such as anti-bacterial, anti-viral, anti-fungal, and antiparasitic medications. Anti-infective therapies help in the treatment of minor infections as well as many serious infectious diseases such as tuberculosis and pneumonia. These therapies have revolutionized healthcare as they enrich and extend the life of patients suffering from all types of infectious diseases.

Get Exclusive Sample PDF @: https://www.premiummarketinsights.com/sample/TIP00012464?utm_source=OpenPr&utm_medium=10640

Analysis of the Top Market Players:

1. Abbott
2. Allergan Plc.
3. Astellas Pharma Inc.
4. Merck & Co., Inc.
5. Bayer AG
6. Bristol-Myers Squibb Company
7. Boehringer Ingelheim International GmbH
8. F. Hoffmann-La Roche Ltd.
9. Gilead Sciences, Inc.
10. GlaxoSmithKline plc.
11. Novartis AG

In this report, the market has been segmented on the basis of:
Type (Anti-Viral, Anti-Bacterial, Anti-Fungal, and Others)
Range (Narrow Spectrum and Broad Spectrum),

Get full Report Description, TOC, Table of Figure, Chart, etc. @: https://www.premiummarketinsights.com/reports-tip/anti-infective-agents-market

Chronic diseases are conditions that develop over an extended period due to a combination of genetic, physiological, environmental, and behavioral variables. The four primary categories of noncommunicable diseases (NCDs) are diabetes, cancer, chronic respiratory diseases (such as chronic obstructive pulmonary disease and asthma), and cardiovascular disorders (including heart attacks and stroke). NCDs account for 41 million annual deaths, or 71% of all fatalities worldwide, according to the WHO. Over 15 million people aged 30 to 69 die from an NCD yearly; 85% of these premature deaths occur in low- and middle-income nations. The majority of NCD deaths, or 17.9 million people per year, are caused by cardiovascular diseases, followed by malignancies (9.3 million), respiratory illnesses (4.1 million), and diabetes (1.5 million).

The rising prevalence of anti-infective resistance, which has now become a global public health issue, poses a hazard to human health. Anti-bacterial, anti-viral, anti-fungal, and antiparasitic drugs are anti-infective drugs that work to prevent or treat infections. Antibiotics are chemically derived antimicrobial medications that cure and prevent bacterial illnesses by eradicating or preventing their growth. Azithromycin, clarithromycin, and erythromycin are examples of macrolides, which have historically been the main antibiotic classes and were studied for their potential role in the secondary prevention of coronary heart diseases.

Buy this research report at @: https://www.premiummarketinsights.com/buy/TIP00012464?utm_source=OpenPr&utm_medium=10640

Contact Us:
If you have any queries about this report or if you would like further information, please
Contact Person: Ankit Mathur
Phone: +1-646-491-9876
Email: sales@premiummarketinsights.com

About Us:
Premium Market Insights is a one stop shop of market research reports and solutions to various companies across the globe. We help our clients in their decision support system by helping them choose most relevant and cost-effective research reports and solutions from various publishers.
The market research industry has changed in last decade. As corporate focus has shifted to niche markets and emerging countries, a number of publishers have stepped in to fulfil these information needs. We have experienced and trained staff that helps you navigate different options and lets you choose best research solution at most effective cost.
Premium Market Insights has an extensive coverage of industry reports, company reports and country reports across all industries. In case your research needs are not met by syndicated reports offered by leading publishers, we can help you by offering a customized research solution by liaising with different research agencies saving your valuable time and money.
We provide best in class customer service and our customer support team is always available to help you on your research queries. Our commitment to customer service is best exemplified by free analyst support that we offer to our clients which sets us apart from any other provider. We also offer enterprise subscriptions which provide significant cost savings to our clients.

This release was published on openPR.